Rebecca Haberman is a Rheumatology/Immunology physician affiliated with NYU Langone Health. OpenAlex indexes 50 publications with 1,774 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
550 First Avenue
Nyu Langone Medical Center
New York, NY 10016
Telephone
212-263-5506Provider last certified this registry record 18 Aug 2022.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- UCB, Inc.Program year20253 payments
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- Janssen Biotech, Inc.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
53.2%TNF inhibitor23.6%Enbrel Sureclick62%Humira(Cf) Pen38%Part D<11 patientsFolate Analog Metabolic Inhibitor20.7%Methotrexate100%Part D≥20 patients+ 2 more classes in this area
Antiparasitic
15%Antimalarial15%Hydroxychloroquine Sulfate100%Part D<11 patientsMusculoskeletal
14.6%Central alpha-2 Adrenergic Agonist9.6%Tizanidine Hcl100%Part D<11 patientsNonsteroidal Anti-inflammatory Drug5%Diclofenac Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Clinical and neuroimaging determinants of persistent joint pain in psoriatic arthritis
New York University School of Medicine
FY2026$175,824K23AR082955 - Clinical and neuroimaging determinants of persistent joint pain in psoriatic arthritis
New York University School of Medicine
FY2025$175,824K23AR082955 - Clinical and neuroimaging determinants of persistent joint pain in psoriatic arthritis
New York University School of Medicine
FY2024$175,824K23AR082955
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Examining the Role of Wearables in Inflammatory Arthritis Care: A Narrative Literature Review
The Journal of Rheumatology
2026 - Targeting Obesity in Psoriatic Arthritis: Is It Time for a Paradigm Change?
Arthritis & Rheumatology
2026 - Beyond Pain Intensity: The Relationship Between Pain Catastrophizing and Quality of Life in Psoriatic Arthritis
The Journal of Rheumatology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Gareth Morgan, MD
NYU Langone Health
Nathan Levin, MD
NYU Langone Health
Ira Jacobson, MD
NYU Langone Health
Michael Zelefsky, MD
NYU Langone Health
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”